title: Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.
abstract: The complexity of cardiovascular responses produced by 5-hydroxytryptamine (5-HT, serotonin), including bradycardia or tachycardia, hypotension or hypertension, and vasodilatation or vasoconstriction, has been explained by the capability of this monoamine to interact with different receptors in the central nervous system (CNS), on the autonomic ganglia and postganglionic nerve endings, on vascular smooth muscle and endothelium, and on the cardiac tissue. Depending, among other factors, on the species, the vascular bed under study, and the experimental conditions, these responses are mainly mediated by 5-HT(1), 5-HT(2), 5-HT(3), 5-HT(4), 5-ht(5A/5B), and 5-HT(7) receptors as well as by a tyramine-like action or unidentified mechanisms. It is noteworthy that 5-HT(6) receptors do not seem to be involved in the cardiovascular responses to 5-HT. Regarding heart rate, intravenous (i.v.) administration of 5-HT usually lowers this variable by eliciting a von Bezold-Jarisch-like reflex via 5-HT(3) receptors located on sensory vagal nerve endings in the heart. Other bradycardic mechanisms include cardiac sympatho-inhibition by prejunctional 5-HT(1B/1D) receptors and, in the case of the rat, an additional 5-ht(5A/5B) receptor component. Moreover, i.v. 5-HT can increase heart rate in different species (after vagotomy) by a variety of mechanisms/receptors including activation of: (1) myocardial 5-HT(2A) (rat), 5-HT(3) (dog), 5-HT(4) (pig, human), and 5-HT(7) (cat) receptors; (2) adrenomedullary 5-HT(2) (dog) and prejunctional sympatho-excitatory 5-HT(3) (rabbit) receptors associated with a release of catecholamines; (3) a tyramine-like action mechanism (guinea pig); and (4) unidentified mechanisms (certain lamellibranch and gastropod species). Furthermore, central administration of 5-HT can cause, in general, bradycardia and/or tachycardia mediated by activation of, respectively, 5-HT(1A) and 5-HT(2) receptors. On the other hand, the blood pressure response to i.v. administration of 5-HT is usually triphasic and consists of an initial short-lasting vasodepressor response due to a reflex bradycardia (mediated by 5-HT(3) receptors located on vagal afferents, via the von Bezold-Jarisch-like reflex), a middle vasopressor phase, and a late, longer-lasting, vasodepressor response. The vasopressor response is a consequence of vasoconstriction mainly mediated by 5-HT(2A) receptors; however, vasoconstriction in the canine saphenous vein and external carotid bed as well as in the porcine cephalic arteries and arteriovenous anastomoses is due to activation of 5-HT(1B) receptors. The late vasodepressor response may involve three different mechanisms: (1) direct vasorelaxation by activation of 5-HT(7) receptors located on vascular smooth muscle; (2) inhibition of the vasopressor sympathetic outflow by sympatho-inhibitory 5-HT(1A/1B/1D) receptors; and (3) release of endothelium-derived relaxing factor (nitric oxide) by 5-HT(2B) and/or 5-HT(1B/1D) receptors. Furthermore, central administration of 5-HT can cause both hypotension (mainly mediated by 5-HT(1A) receptors) and hypertension (mainly mediated by 5-HT(2) receptors). The increasing availability of new compounds with high affinity and selectivity for the different 5-HT receptor subtypes makes it possible to develop drugs with potential therapeutic usefulness in the treatment of some cardiovascular illnesses including hypertension, migraine, some peripheral vascular diseases, and heart failure.
authors: Departamento de Farmacobiología, Cinvestav-Coapa, Tenorios 235, Col. Granjas-Coapa, Delegación Tlalpan, 14330 México D.F., Mexico. carlos_villalon@infosel.net.mx
authors: Carlos M
authors: CM
authors: Villalón
authors: David
authors: D
authors: Centurión
mesh_terms: D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000503:physiopathology; D002545:Brain Ischemia / Q000188:drug therapy / Q000503:physiopathology; D002320:Cardiovascular Physiological Phenomena / Q000187:drug effects*; D002319:Cardiovascular System / Q000187:drug effects / Q000294:innervation; D005728:Ganglia, Sympathetic / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D008024:Ligands; D008881:Migraine Disorders / Q000188:drug therapy / Q000503:physiopathology; D016491:Peripheral Vascular Diseases / Q000188:drug therapy / Q000503:physiopathology; D011985:Receptors, Serotonin / Q000145:classification / Q000502:physiology*; D012701:Serotonin / Q000494:pharmacology* / Q000502:physiology; D018490:Serotonin Agents / Q000494:pharmacology
chemical_list: D008024:Ligands; D011985:Receptors, Serotonin; D018490:Serotonin Agents; D012701:Serotonin
references: Lancet. 2001 Oct 13;358(9289):1230-4
references: 11675061
references: Br J Pharmacol. 1999 Oct;128(3):730-4
references: 10516655
references: Eur J Pharmacol. 1982 Nov 19;85(2):225-7
references: 6129985
references: Br J Pharmacol. 1998 Apr;123(8):1561-70
references: 9605562
references: J Pharmacol Exp Ther. 1981 Jul;218(1):217-30
references: 6113280
references: Nature. 1952 May 10;169(4306):800-1
references: 14941051
references: Naunyn Schmiedebergs Arch Pharmacol. 1999 Apr;359(4):331-8
references: 10344532
references: Pain. 1996 Feb;64(2):315-22
references: 8740609
references: Eur J Pharmacol. 1989 Sep 22;168(3):369-74
references: 2583242
references: Behav Brain Res. 1996;73(1-2):157-61
references: 8788495
references: Br J Clin Pharmacol. 1999 Jan;47(1):75-82
references: 10073743
references: Arch Int Pharmacodyn Ther. 1995 Jan-Feb;329(1):111-9
references: 7639613
references: Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):124-30
references: 2939353
references: N Engl J Med. 2004 Mar 11;350(11):1104-10
references: 15014183
references: J Auton Pharmacol. 1989 Jun;9(3):201-10
references: 2545718
references: Pain. 1991 Jun;45(3):283-91
references: 1876437
references: Life Sci. 1999;64(20):1839-47
references: 10350358
references: Trends Pharmacol Sci. 1999 Dec;20(12):490-5
references: 10603491
references: Mol Interv. 2005 Oct;5(5):304-11
references: 16249526
references: Br J Pharmacol. 1991 Apr;102(4):938-42
references: 1855122
references: Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:33-5
references: 2285648
references: J Exp Biol. 1997;200(Pt 15):2123-35
references: 9320037
references: Physiol Rev. 1958 Apr;38(2):277-335
references: 13542212
references: Stroke. 1990 Dec;21(12 Suppl):IV161-3
references: 2148035
references: Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):371-7
references: 2255330
references: Pain. 1996 Oct;67(2-3):375-8
references: 8951932
references: Br J Pharmacol. 1995 Dec;116(8):3330-6
references: 8719815
references: Neuropharmacology. 1997 Jan;36(1):83-91
references: 9144644
references: Pharmacol Biochem Behav. 2002 Apr;71(4):533-54
references: 11888546
references: Br J Pharmacol. 1990 Aug;100(4):665-7
references: 2207493
references: Neuroreport. 1997 Jul 7;8(9-10):2237-40
references: 9243618
references: Circ Res. 1985 Jul;57(1):46-54
references: 4006105
references: Pharmacol Rev. 1994 Jun;46(2):157-203
references: 7938165
references: Life Sci. 1988;43(18):1441-9
references: 3185102
references: J Neurophysiol. 2004 Oct;92(4):2487-96
references: 15140904
references: Br J Pharmacol. 1987 Oct;92 (2):417-27
references: 3676602
references: Br J Pharmacol. 2003 Oct;140(4):725-35
references: 14504136
references: Naunyn Schmiedebergs Arch Pharmacol. 2004 Sep;370(3):157-66
references: 15365689
references: J Cardiovasc Pharmacol. 1989 Jan;13(1):45-51
references: 2468935
references: Eur J Pharmacol. 1993 Jan 5;230(1):103-5
references: 8428599
references: J Cardiovasc Pharmacol. 1991;17 Suppl 5:S48-53
references: 1717773
references: Hepatology. 1991 Dec;14(6):1174-8
references: 1959867
references: Naunyn Schmiedebergs Arch Pharmacol. 2000 Aug;362(2):169-76
references: 10961380
references: Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):408-12
references: 8380639
references: Br J Pharmacol. 2000 Oct;131(3):562-8
references: 11015308
references: Neuroscience. 1993 Jul;55(1):235-52
references: 8350989
references: Biochem Pharmacol. 1994 Aug 17;48(4):683-8
references: 7915903
references: Arch Int Pharmacodyn Ther. 1985 Oct;277(2):235-52
references: 2933009
references: Br J Pharmacol. 1995 Sep;116(2):1715-7
references: 8528548
references: J Neurol. 1991;238 Suppl 1:S53-6
references: 2045832
references: Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):220-7
references: 14673512
references: J Biol Chem. 1948 Dec;176(3):1243-51
references: 18100415
references: Am J Physiol. 1999 Mar;276(3 Pt 2):H944-52
references: 10070078
references: Pharmacol Ther. 2006 Sep;111(3):674-706
references: 16960982
references: J Cardiovasc Pharmacol. 1990;15 Suppl 7:S17-34
references: 1702484
references: Naunyn Schmiedebergs Arch Pharmacol. 2000 Jun;361(6):665-71
references: 10882042
references: Br J Pharmacol. 1976 Oct;58(2):211-21
references: 184872
references: J Pharmacol Exp Ther. 1988 Jan;244(1):1-10
references: 2961880
references: Am J Physiol Regul Integr Comp Physiol. 2003 Mar;284(3):R782-91
references: 12611395
references: J Neurophysiol. 2004 Oct;92(4):2468-86
references: 15140903
references: Fed Proc. 1983 Feb;42(2):223-7
references: 6295823
references: Clin Exp Hypertens. 1994 Nov;16(6):779-98
references: 7858559
references: J Pharmacol Exp Ther. 1990 Feb;252(2):683-8
references: 1968974
references: J Physiol. 2005 Feb 15;563(Pt 1):319-31
references: 15611034
references: Br J Pharmacol. 2000 Jan;129(1):177-83
references: 10694218
references: Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:19-25
references: 2285646
references: Eur J Pharmacol. 1989 Oct 24;170(1-2):109-11
references: 2612560
references: J Biol Chem. 1949 Oct;180(3):961-9
references: 18139191
references: Pharmacol Ther. 1995 May;66(2):339-68
references: 7667401
references: Neuropharmacology. 1999 Aug;38(8):1083-152
references: 10462127
references: Br J Pharmacol. 1990 Aug;100(4):879-85
references: 2169944
references: Circ Res. 2005 Aug 5;97(3):268-76
references: 16002744
references: Mol Pharmacol. 2000 Jan;57(1):75-81
references: 10617681
references: Proc West Pharmacol Soc. 2002;45:199-210
references: 12434581
references: Behav Brain Res. 1996;73(1-2):301-4
references: 8788524
references: Brain Res Bull. 2001 Nov 15;56(5):425-39
references: 11750788
references: Br J Pharmacol. 1997 Apr;120(7):1319-27
references: 9105708
references: Br J Pharmacol. 1993 Nov;110(3):1172-4
references: 8298805
references: Br J Pharmacol Chemother. 1957 Sep;12(3):323-8
references: 13460238
references: Am J Physiol Regul Integr Comp Physiol. 2000 Nov;279(5):R1776-86
references: 11049861
references: Br J Pharmacol. 1991 Jan;102(1):107-12
references: 2043916
references: Naunyn Schmiedebergs Arch Pharmacol. 1989 Mar;339(3):259-62
references: 2725703
references: Naunyn Schmiedebergs Arch Pharmacol. 1994 Sep;350(3):225-9
references: 7824037
references: J Pharmacol Exp Ther. 1990 Jan;252(1):387-95
references: 2137176
references: Br J Pharmacol. 1995 Sep;116(2):1751-6
references: 8528555
references: Am J Med. 1995 Sep;99(3):249-54
references: 7653484
references: Br J Pharmacol. 1992 Oct;107(2):591-6
references: 1422600
references: Eur J Pharmacol. 1997 Jul 23;331(2-3):169-74
references: 9274976
references: Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):550-6
references: 8938651
references: Rev Med Interne. 2004 Oct;25(10):720-31
references: 15471598
references: Neuropharmacology. 1986 Jun;25(6):563-76
references: 2875415
references: Br J Pharmacol. 1994 Feb;111(2):616-24
references: 8004405
references: Naunyn Schmiedebergs Arch Pharmacol. 1992 Nov;346(5):482-5
references: 1335123
references: Stroke. 1990 Dec;21(12 Suppl):IV164-6
references: 2148036
references: Br J Pharmacol. 1998 Jul;124(5):1001-11
references: 9692787
references: Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:53-8
references: 2285651
references: Trends Pharmacol Sci. 1998 Aug;19(8):311-6
references: 9745358
references: Br J Pharmacol. 2001 Mar;132(5):991-8
references: 11226129
references: Eur J Pharmacol. 1992 Nov 10;222(2-3):185-91
references: 1451731
references: J Vet Pharmacol Ther. 1994 Jun;17(3):218-25
references: 7933060
references: Eur J Pharmacol. 2004 Jan 26;484(2-3):287-90
references: 14744615
references: J Auton Nerv Syst. 1988 Apr;22(3):229-36
references: 3418016
references: Br J Pharmacol. 1997 Jul;121(6):1187-95
references: 9249256
references: Naunyn Schmiedebergs Arch Pharmacol. 1988 Jan;337(1):1-8
references: 3368008
references: Science. 1983 Jul 15;221(4607):273-4
references: 6574604
references: Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):365-73
references: 3431594
references: Naunyn Schmiedebergs Arch Pharmacol. 2001 Jan;363(1):73-80
references: 11191839
references: Pharmacol Ther. 2006 Sep;111(3):707-14
references: 16516972
references: Trends Pharmacol Sci. 1991 Dec;12(12):444-6
references: 1665260
references: Br J Pharmacol. 2006 Sep;149(1):82-91
references: 16880765
references: Jpn J Pharmacol. 2002 Jul;89(3):242-8
references: 12184729
references: Br J Pharmacol. 2007 Jan;150(2):143-52
references: 17160012
references: Nat Med. 2002 Oct;8(10 ):1129-35
references: 12244304
references: Eur J Pharmacol. 1994 Feb 3;252(2):161-6
references: 8157057
references: Pharmacol Ther. 1994;62(3):283-324
references: 7972337
references: Br J Pharmacol. 2002 Mar;135(6):1531-9
references: 11906967
references: Circulation. 1999 Jan 5-12;99(1):156-61
references: 9884392
references: Br J Pharmacol. 1995 Jan;114(2):400-4
references: 7881740
references: Am J Physiol. 1953 Sep;174(3):436-44
references: 13092269
references: Eur J Pharmacol. 1988 Jan 5;145(1):67-73
references: 2894997
references: J Pharmacol Exp Ther. 1985 Oct;235(1):76-80
references: 4045729
references: Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):471-7
references: 8391650
references: Naunyn Schmiedebergs Arch Pharmacol. 2004 Jul;370(1):46-53
references: 15224175
references: Eur J Pharmacol. 1989 May 19;164(2):213-22
references: 2759173
references: Cephalalgia. 2002 Dec;22(10):799-806
references: 12485205
references: Eur J Pharmacol. 1993 Nov 30;250(1):67-75
references: 7907025
references: Eur J Pharmacol. 2004 Oct 19;502(3):239-42
references: 15476750
references: Brain Res. 2007 May 4;1144:82-90
references: 17320834
references: Pharmacol Rev. 1994 Sep;46(3):231-43
references: 7831380
references: Mol Pharmacol. 1996 Dec;50(6):1567-80
references: 8967979
references: Life Sci. 1994;54(10):641-4
references: 8107508
references: Neuropharmacology. 1984 Dec;23(12B):1473-86
references: 6527747
references: Naunyn Schmiedebergs Arch Pharmacol. 1987 Sep;336(3):245-50
references: 3683595
references: Life Sci. 1995;57(8):803-12
references: 7637553
references: Eur J Pharmacol. 1993 Aug 10;240(1):9-20
references: 8405128
references: J Physiol. 1900 Dec 31;26(1-2):48-71
references: 16992567
references: Cardiovasc Res. 2005 Mar 1;65(4):869-78
references: 15721867
references: J Biol Chem. 1948 Jun;174(2):735-41
references: 18865641
references: Br J Pharmacol. 1993 Feb;108(2):431-5
references: 8448594
references: Cephalalgia. 1996 Nov;16(7):497-502
references: 8933995
references: Br J Pharmacol. 2001 Mar;132(5):983-90
references: 11226128
references: Br J Pharmacol. 2000 Jun;130(3):692-8
references: 10821800
references: Headache. 1972 Jul;12(2):44-54
references: 5056178
references: Naunyn Schmiedebergs Arch Pharmacol. 1997 Jul;356(1):90-9
references: 9228195
references: Br J Pharmacol. 1992 Dec;107(4):1020-8
references: 1467825
references: Neuropharmacology. 1997 Apr-May;36(4-5):419-28
references: 9225265
references: Cephalalgia. 2001 Sep;21(7):727-32
references: 11595000
references: Clin Exp Pharmacol Physiol. 1983 Sep-Oct;10(5):535-42
references: 6315283
references: Br J Pharmacol. 1988 Aug;94(4):1123-32
references: 2850055
references: Hypertension. 1991 May;17(5):593-602
references: 2022404
references: Br J Pharmacol. 1999 Feb;126(3):585-94
references: 10188968
references: Clin Neuropharmacol. 1996 Apr;19(2):101-28
references: 8777766
references: Br J Pharmacol. 1995 Nov;116(5):2385-90
references: 8581273
references: Mol Pharmacol. 1979 Nov;16(3):687-99
references: 530254
references: Neuropharmacology. 1995 Mar;34(3):255-61
references: 7630480
references: Chest. 1998 Sep;114(3 Suppl):242S-247S
references: 9741576
references: Eur J Pharmacol. 1998 Nov 27;362(1):69-72
references: 9865532